BioMarin Pharmaceutical | BMRN - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 195.44B 5.55B 2026-06
Bayer EUR 47.56B 8.87B 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
Incyte USD 22.65B 3.92B 2026-06
Insmed USD 23.11B 12.19B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
United Therapeutics USD 23B 2.19B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06